EGFR and lung carcinoma: A previous report showed that cytotoxic T cells and the chemokines that recruit them are associated with the efficacy of ICIs in EGFR-mutant lung cancer (Hayashi et al. 2022), suggesting that some EGFR-lung cancers have an inflamed TME.